Ethep over on Yahoo suggested that Amarantus might
Post# of 30067
Posted On: 01/22/2015 10:02:14 PM
Ethep over on Yahoo suggested that Amarantus might use the blood samples from the LP002 Lympro testing and apply the Georgetown tests on them. I don't know if that is possible, but why not? It would sure speed up the time it takes for us to offer Georgetowns blood tests in research trials. Gerald hasn't made this clear, but he seems to have indicated that we'd be offering the entire suite to pharmas.....soon....not in 2 years.
If we used the old blood from the 140 we tested Lympro on and ran the Georgetown tests....then all we'd have to do is get the Georgetown tests validated in an ICON lab. (3 months?) Could it be by summer we are offered pharmas the entire suite, both here and in Europe?
Holy Toledo!! I think the announcements the last couple of weeks have been seismic! The ass hole manipulating the stock price will turn eventually.
I suspect pharmas are calling Gerald and presenting all sorts of ways of doing deals to get in on our Diagnostic Powerhouse. I would imagine the up list will happen in the April time frame and the spin off shortly thereafter? When you add up all the revenue the MS and the new alzheimer suite of tests can bring in over the next couple of years....the entire Diagnostic company market cap could be worth 3 billion in 2 years!
What might a pharma pays us now up front and in milestone and royalty payments? That is what Gerald is probably taking bids on now!
It's a very exciting time!
If we used the old blood from the 140 we tested Lympro on and ran the Georgetown tests....then all we'd have to do is get the Georgetown tests validated in an ICON lab. (3 months?) Could it be by summer we are offered pharmas the entire suite, both here and in Europe?
Holy Toledo!! I think the announcements the last couple of weeks have been seismic! The ass hole manipulating the stock price will turn eventually.
I suspect pharmas are calling Gerald and presenting all sorts of ways of doing deals to get in on our Diagnostic Powerhouse. I would imagine the up list will happen in the April time frame and the spin off shortly thereafter? When you add up all the revenue the MS and the new alzheimer suite of tests can bring in over the next couple of years....the entire Diagnostic company market cap could be worth 3 billion in 2 years!
What might a pharma pays us now up front and in milestone and royalty payments? That is what Gerald is probably taking bids on now!
It's a very exciting time!
(0)
(0)